“showed a trend”

In comparison, participants from the villages with a moderate epilepsy prevalence showed a trend of higher odds ratio of low knowledge ( p = 0.052) than those villages with low prevalence.

Serum analysis revealed that CrPyr significantly increased GSH levels in RMT mice ( P < 0.05) and showed a trend toward decreasing glutathione disulfide (GSSG) levels ( P = 0.052; Fig. 7 C).

Although the results did not reach statistical significance, high expression of FOSL1 showed a trend towards poor prognosis in patients ( p = 0.052) (Fig. 1 E).

While the frontal cortex displayed a positive correlation, this was not significant, and the SM cortex showed a trend toward negative correlation ( theta FP : γ/α: R = −0.49, p = 0.052, theta FC : γ/α: R = −0.53, p = 0.064, beta FC : γ/α: R = −0.32, p = 0.39).

Even when metastases were present, hypothyroid patients had significantly fewer affected nodes ( p = 0.009) and showed a trend toward lower overall lymph node burden ( p = 0.052).

However, patients with UA showed a trend toward greater necrotic volume (9.4±3.8% vs. 7.5±3.7%, p =0.052) and less fibro-fatty tissue (15.1±8.1% vs. 18.3±7.6%, p =0.110) than SA patients.

Additionally, Lachnospiraceae Group NK4A136 ASV182N showed a trend toward enrichment ( p = 0.052) in the 2iKO mice, whereas Robinsoniella peoriensis ASV17QD trended toward a reduction in the 2iKO ( p = 0.093, Fig. 5A ).

Participants who were not virally suppressed (i.e., HIV RNA >50 copies/mL) at week 12 (6/11) showed a trend for higher BDG levels in plasma (median 52 pg/mL, range 12–122 pg/mL) when compared to those who were virally suppressed (median 9 pg/mL, range 3–46 pg/mL; p = 0.052, Mann–Whitney U test), while there was no difference at week 24.

However, the combination of fluticasone and salmeterol showed a trend towards a significant ( P = .052) reduction of all-cause mortality by 17.5% in 3 years compared to placebo.

Although the percent errors of Task 1 ( Figure 2A ) and Task 2 for non-Stroop trials ( Figure 2D ) did not reach statistical significance (Spearman's correlation coefficient = 0.386; p = 0.126; Spearman's correlation coefficient = 0.391; p = 0.121, respectively), Task 2 showed a trend toward a positive association (Spearman's correlation coefficient = 0.478; p = 0.052) ( Figure 2B ).

Albumin levels showed a trend towards an increase when compared to controls ( p = 0.052).

N stage also showed a trend towards improved LRFS ( P =0.052).

The mice given high-dose semaglutide combined with BAM15 also showed a trend for decreased AUC compared with BAM15 alone (1734 ± 58 mmolL −1 ·min, P =0.052) or high-dose semaglutide alone (1734 ± 230 mmolL −1 ·min, P =0.052) ( Figure 4 B).

The Shannon index showed a trend toward lower diversity in Duroc boars compared to Yorkshire boars ( P = 0.052; Fig. 2D ).

The PIK3CA mutation located in the kinase domain showed a trend toward a shorter OS compared with wild-type tumors (multivariate HR = 1.56; 95%CI: 1.00-2.44; P = 0.052).

Stage III/IV showed a trend towards larger tumor size (p = 0.052), older age (p = 0.002), and chemotherapy (p < 0.001).

The ventral anterior insula showed a trend‐level group difference, t 188 = 1.96, p = 0.052, with a moderate effect size in the high‐intensity condition ( g = 0.32).

Multivariate analysis showed a trend for high TILs to be an independent factor of low NR rate in all 94 cases {OR (95% CI): 0.126 (0.015–1.020); P = 0.052, Fig. 4 d}.

However, only the patients with TP53 mutations had a significantly increased probability of shorter OS (P=0.034) and PFS (P=0.011), and patients with DNMT3A mutations showed a trend toward shorter PFS (P=0.052).

Additionally, higher CUDIT‐R scores showed a weak association with lower Tp‐e/QTc (r=−0.220, P =0.019), and showed a trend toward a weak association with lower Tp‐e (r=−0.183, P =0.052) and Tp‐e/QT (r=−0.174, P =0.064).

Time to RT ≥ 49 days showed a trend for worse PFS in univariate testing (64.6% ± 9.1% vs 80.4% ± 2.2%; P = .052, Fig 2 C).

Resistant cell lines showed a trend toward a lower basal growth rate per day compared to sensitive cell lines (0.3 ± 0.06 vs . 0.5 ± 0.04, respectively; P = 0.052).

One study observed that the levels of serum IL-6 in patients with alcohol dependence did not significantly decrease although they showed a trend from baseline to 16-week follow-up ( p = 0.052) [ 70 ].

Neurons from pilocarpine‐treated rats showed a trend for development of very weak LTP measured 30 min following WPP (paired comparison to baseline: 124.8 ± 11.6%, n = 13 cells, n = 8 animals, P = 0.052).

Moreover, high DIAPH3, HLA‐E , and LMAN1 expression was significantly associated with shorter overall survival ( P = .043, P = 0.018, and P = .014, resp.; Figure S2 ), and high PPP2R5E and UHMK1 expression showed a trend toward association with shorter overall survival in MIBC ( P = .052 and P = .078, resp.; Figure S2 ).